Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

DSSTox_CID_365

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 23 USDMF, 11 CEP/COS, 7 JDMF, 3 EU WC, 13 KDMF, 22 NDC API, 1 VMF, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

178 Drugs in Development

178 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

451 FDF Dossiers, 55 FDA Orange Book, 301 Europe, 20 Canada, 48 Australia, 7 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 1 Rochem International Inc, 2 SPI Pharma, 9 DKSH, 1 PMC Isochem, 1 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 19 BASF, 1 Bioplus Life Sciences, 1 Clariant, 3 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 1 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Pluviaendo, 1 Qualicaps, 11 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Solubilizers, 30 Topical, 21 Parenteral, 18 Film Formers & Plasticizers, 16 Thickeners and Stabilizers, 15 Emulsifying Agents, 12 Coating Systems & Additives, 10 Fillers, Diluents & Binders, 10 Surfactant & Foaming Agents, 8 Empty Capsules, 7 Taste Masking, 6 Granulation, 6 Controlled & Modified Release, 4 API Stability Enhancers, 4 Direct Compression, 4 Lubricants & Glidants, 3 Co-Processed Excipients, 3 Coloring Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 165 News #PharmaBuzz

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 43 Regulatory FDF Prices, 14 Annual Reports

MARKET PLACE

31 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 2 US Exclusivities, 49 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 1 JP, 5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	AbbVie Inc	U.S.A	AbbVie Inc. North Chicago US	R1-CEP 1998-093 - Rev 07	Ciclosporin	2020-10-09	Valid	Chemical and TSE		994
29/11/2025	TAPI Technology & API Services	Israel	TAPI CZECH INDUSTRIES S.R.O. Opava CZ	CEP 2002-152 - Rev 07	Ciclosporin	2025-03-11	Valid	Chemical		994

DSSTox_CID_365

DSSTox_CID_365

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers

23 USDMF

11 CEP/COS

7 JDMF

3 EU WC

13 KDMF

22 NDC API

1 VMF

14 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

178 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

451 FDF Dossiers

55 FDA Orange Book

301 Europe

20 Canada

48 Australia

7 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Evonik

1 Rochem International Inc

2 SPI Pharma

9 DKSH

1 PMC Isochem

1 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

2 Kirsch Pharma

4 ACG Worldwide

7 Actylis

1 Aeon Procare

19 BASF

1 Bioplus Life Sciences

1 Clariant

3 Corel Pharma Chem

1 Esteem Industries

2 Finar

7 Gangwal Chemicals

3 Lonza Capsugel

1 Lubrizol Life Science Health

1 Microlex e.U

3 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Pluviaendo

1 Qualicaps

11 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Solubilizers

30 Topical

21 Parenteral

18 Film Formers & Plasticizers

16 Thickeners and Stabilizers

15 Emulsifying Agents

12 Coating Systems & Additives

10 Fillers, Diluents & Binders

10 Surfactant & Foaming Agents

8 Empty Capsules

7 Taste Masking

6 Granulation

6 Controlled & Modified Release

CAPSULE;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons